Abstract
Purpose: Bleomycin is an antibiotic medication that inhibits the synthesis of DNA, RNA, and proteins and is now used in a variety of medical conditions including vascular anomalies. The aim of this study was to evaluate the clinical efficacy of transmucosal intralesional injection of bleomycin in the management of tongue lymphatic malformations. Method: A single institutional case series was presented on patients with recalcitrant lymphatic malformations of the tongue who were treated with bleomycin. Age at the time of injection, gender, number of treatments, amount of bleomycin injected per session, post-injection complications, pre- and post-injection symptoms, and anatomic extent of the lymphatic malformation were all recorded and analyzed. Results: Five patients received transmucosal bleomycin and were followed over a 10-month period. The patients included 4 females and 1 male, aged from 3.25 to 36 years (average 13.52 years). Four patients had one treatment while 1 required two treatments. A total of 1 to 6 units were injected per session. Overall reduction in size of the lymphatic malformation and improvement in all symptoms were observed in the patients by day 14. Average follow-up was 9 to 12 months. Conclusion: Intralesional injection of bleomycin is an effective treatment modality in patients with lymphatic malformations of the tongue.
Highlights
IntroductionVascular malformations manifest as either high-flow lesions (arteriovenous malformations and fistulae) or low-
Vascular malformations manifest as either high-flow lesions or low-How to cite this paper: Cerrati, E.W., O, T.M., Binetter, D., Bernstein, Y. and Waner, M. (2015) Transmucosal Bleomycin for Tongue Lymphatic Malformations
Isolated superficial Lymphatic malformations (LMs) or those confined to only a portion of the tongue allow surgical resection to be an effective treatment
Summary
Vascular malformations manifest as either high-flow lesions (arteriovenous malformations and fistulae) or low-. Lymphatic malformations (LMs) are composed of dilated lymphatic vessels with inappropriate drainage patterns and are lined with endothelial cells They are estimated to occur in 0.5% of the general population and commonly result in a painless focal mass (macrocystic) or diffuse tissue swelling or overgrowth (microcystic) [2]. An antibiotic with cytotoxic antitumor properties via the inhibition of DNA, RNA, and protein synthesis, has been used in a variety of medical conditions including in a role as a sclerosant. It is favored by some clinicians because of its clinical efficacy combined with a low incidence of significant postoperative edema [5]-[7]. Bleomycin’s use has yet to be applied to oral cavity lymphatic malformations
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Otolaryngology and Head & Neck Surgery
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
